APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

C1 Esterase Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global C1 Esterase Inhibitors Market Analysis and Forecast 2026-2032

Report ID 173973510229 December 2025195 pages

Choose your research edition.

Industry ResearchC1 Esterase Inhibitors Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal C1 Esterase Inhibitors Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal C1 Esterase Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C1 Esterase Inhibitors Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal C1 Esterase Inhibitors Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global C1 Esterase Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for C1 Esterase Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for C1 Esterase Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for C1 Esterase Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for C1 Esterase Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of C1 Esterase Inhibitors include Takeda, Pharming Healthcare and CSL Behring, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for C1 Esterase Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of C1 Esterase Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for C1 Esterase Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the C1 Esterase Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global C1 Esterase Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for C1 Esterase Inhibitors sales, projected growth trends, production technology, application and end-user industry.

C1 Esterase Inhibitors Segment by Company

Takeda

Pharming Healthcare

CSL Behring

C1 Esterase Inhibitors Segment by Type

Recombinant C1-INH

Plasma-derived C1-INH

C1 Esterase Inhibitors Segment by Application

Hospital and Clinic

Pharmacy

Other

C1 Esterase Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C1 Esterase Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C1 Esterase Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C1 Esterase Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of C1 Esterase Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of C1 Esterase Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C1 Esterase Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C1 Esterase Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant C1-INH Major Manufacturers Table 3. Plasma-derived C1-INH Major Manufacturers Table 4. Global C1 Esterase Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital and Clinic Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Other Major Manufacturers Table 8. C1 Esterase Inhibitors Industry Trends Table 9. C1 Esterase Inhibitors Industry Drivers Table 10. C1 Esterase Inhibitors Industry Opportunities and Challenges Table 11. C1 Esterase Inhibitors Industry Restraints Table 12. Global C1 Esterase Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global C1 Esterase Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 14. Global C1 Esterase Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 15. Global C1 Esterase Inhibitors Revenue Market Share by Region (2021-2026) Table 16. Global C1 Esterase Inhibitors Revenue Market Share by Region (2027-2032) Table 17. Global C1 Esterase Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global C1 Esterase Inhibitors Sales by Region (2021-2026) & (K Units) Table 19. Global C1 Esterase Inhibitors Sales by Region (2027-2032) & (K Units) Table 20. Global C1 Esterase Inhibitors Sales Market Share by Region (2021-2026) Table 21. Global C1 Esterase Inhibitors Sales Market Share by Region (2027-2032) Table 22. Global C1 Esterase Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global C1 Esterase Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 24. Global C1 Esterase Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global C1 Esterase Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 26. Global C1 Esterase Inhibitors Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global C1 Esterase Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global C1 Esterase Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global C1 Esterase Inhibitors Manufacturers, Product Type & Application Table 30. Global C1 Esterase Inhibitors Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global C1 Esterase Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global C1 Esterase Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global C1 Esterase Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 35. Global C1 Esterase Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 36. Global C1 Esterase Inhibitors Revenue Market Share by Type (2021-2026) Table 37. Global C1 Esterase Inhibitors Revenue Market Share by Type (2027-2032) Table 38. Global C1 Esterase Inhibitors Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 40. Global C1 Esterase Inhibitors Sales by Type (2027-2032) & (K Units) Table 41. Global C1 Esterase Inhibitors Sales Market Share by Type (2021-2026) Table 42. Global C1 Esterase Inhibitors Sales Market Share by Type (2027-2032) Table 43. Global C1 Esterase Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 44. Global C1 Esterase Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 45. Global C1 Esterase Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global C1 Esterase Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 47. Global C1 Esterase Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 48. Global C1 Esterase Inhibitors Revenue Market Share by Application (2021-2026) Table 49. Global C1 Esterase Inhibitors Revenue Market Share by Application (2027-2032) Table 50. Global C1 Esterase Inhibitors Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 52. Global C1 Esterase Inhibitors Sales by Application (2027-2032) & (K Units) Table 53. Global C1 Esterase Inhibitors Sales Market Share by Application (2021-2026) Table 54. Global C1 Esterase Inhibitors Sales Market Share by Application (2027-2032) Table 55. Global C1 Esterase Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 56. Global C1 Esterase Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 57. Takeda Company Information Table 58. Takeda Business Overview Table 59. Takeda C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Takeda C1 Esterase Inhibitors Product Portfolio Table 61. Takeda Recent Development Table 62. Pharming Healthcare Company Information Table 63. Pharming Healthcare Business Overview Table 64. Pharming Healthcare C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Pharming Healthcare C1 Esterase Inhibitors Product Portfolio Table 66. Pharming Healthcare Recent Development Table 67. CSL Behring Company Information Table 68. CSL Behring Business Overview Table 69. CSL Behring C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. CSL Behring C1 Esterase Inhibitors Product Portfolio Table 71. CSL Behring Recent Development Table 72. North America C1 Esterase Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 73. North America C1 Esterase Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 74. North America C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 75. North America C1 Esterase Inhibitors Sales by Type (2027-2032) & (K Units) Table 76. North America C1 Esterase Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 77. North America C1 Esterase Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 78. North America C1 Esterase Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 79. North America C1 Esterase Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 80. North America C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 81. North America C1 Esterase Inhibitors Sales by Application (2027-2032) & (K Units) Table 82. North America C1 Esterase Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 83. North America C1 Esterase Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 84. North America C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America C1 Esterase Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America C1 Esterase Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 88. North America C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 89. North America C1 Esterase Inhibitors Sales by Country (2027-2032) & (K Units) Table 90. North America C1 Esterase Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 91. North America C1 Esterase Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 92. United States C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 93. Canada C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 94. Mexico C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 95. Europe C1 Esterase Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe C1 Esterase Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 98. Europe C1 Esterase Inhibitors Sales by Type (2027-2032) & (K Units) Table 99. Europe C1 Esterase Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 100. Europe C1 Esterase Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 101. Europe C1 Esterase Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe C1 Esterase Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 104. Europe C1 Esterase Inhibitors Sales by Application (2027-2032) & (K Units) Table 105. Europe C1 Esterase Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 106. Europe C1 Esterase Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 107. Europe C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe C1 Esterase Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe C1 Esterase Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 111. Europe C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 112. Europe C1 Esterase Inhibitors Sales by Country (2027-2032) & (K Units) Table 113. Europe C1 Esterase Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 114. Europe C1 Esterase Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 115. Germany C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 116. France C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 117. U.K. C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 118. Italy C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 119. Russia C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 120. Spain C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 121. Netherlands C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 122. Switzerland C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 123. Sweden C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 124. Poland C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 125. China C1 Esterase Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 126. China C1 Esterase Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 127. China C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 128. China C1 Esterase Inhibitors Sales by Type (2027-2032) & (K Units) Table 129. China C1 Esterase Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 130. China C1 Esterase Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 131. China C1 Esterase Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 132. China C1 Esterase Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 133. China C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 134. China C1 Esterase Inhibitors Sales by Application (2027-2032) & (K Units) Table 135. China C1 Esterase Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 136. China C1 Esterase Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 137. Asia C1 Esterase Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia C1 Esterase Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 140. Asia C1 Esterase Inhibitors Sales by Type (2027-2032) & (K Units) Table 141. Asia C1 Esterase Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 142. Asia C1 Esterase Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 143. Asia C1 Esterase Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia C1 Esterase Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 146. Asia C1 Esterase Inhibitors Sales by Application (2027-2032) & (K Units) Table 147. Asia C1 Esterase Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 148. Asia C1 Esterase Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia C1 Esterase Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia C1 Esterase Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 153. Asia C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 154. Asia C1 Esterase Inhibitors Sales by Country (2027-2032) & (K Units) Table 155. Asia C1 Esterase Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 156. Asia C1 Esterase Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 157. Japan C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 158. South Korea C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 159. India C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 160. Australia C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 161. Taiwan C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 163. SAMEA C1 Esterase Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA C1 Esterase Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA C1 Esterase Inhibitors Sales by Type (2021-2026) & (K Units) Table 166. SAMEA C1 Esterase Inhibitors Sales by Type (2027-2032) & (K Units) Table 167. SAMEA C1 Esterase Inhibitors Sales Price by Type (2021-2026) & (US$/Unit) Table 168. SAMEA C1 Esterase Inhibitors Sales Price by Type (2027-2032) & (US$/Unit) Table 169. SAMEA C1 Esterase Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA C1 Esterase Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA C1 Esterase Inhibitors Sales by Application (2021-2026) & (K Units) Table 172. SAMEA C1 Esterase Inhibitors Sales by Application (2027-2032) & (K Units) Table 173. SAMEA C1 Esterase Inhibitors Sales Price by Application (2021-2026) & (US$/Unit) Table 174. SAMEA C1 Esterase Inhibitors Sales Price by Application (2027-2032) & (US$/Unit) Table 175. SAMEA C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA C1 Esterase Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA C1 Esterase Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 179. SAMEA C1 Esterase Inhibitors Sales by Country (2021-2026) & (K Units) Table 180. SAMEA C1 Esterase Inhibitors Sales by Country (2027-2032) & (K Units) Table 181. SAMEA C1 Esterase Inhibitors Sales Price by Country (2021-2026) & (US$/Unit) Table 182. SAMEA C1 Esterase Inhibitors Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Brazil C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 184. Argentina C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 185. Chile C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 186. Colombia C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 187. Peru C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 189. Israel C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 190. UAE C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 191. Turkey C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 192. Iran C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 193. Egypt C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. C1 Esterase Inhibitors Distributors List Table 197. C1 Esterase Inhibitors Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. C1 Esterase Inhibitors Image Figure 2. Global C1 Esterase Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C1 Esterase Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant C1-INH Image Figure 5. Plasma-derived C1-INH Image Figure 6. Global C1 Esterase Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global C1 Esterase Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital and Clinic Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global C1 Esterase Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global C1 Esterase Inhibitors Revenue (2021-2032) & (US$ Million) Figure 13. Global C1 Esterase Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global C1 Esterase Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global C1 Esterase Inhibitors Revenue Market Share by Region (2021-2032) Figure 16. Global C1 Esterase Inhibitors Sales (2021-2032) & (K Units) Figure 17. Global C1 Esterase Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global C1 Esterase Inhibitors Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico C1 Esterase Inhibitors Sales YoY (2021-2032) & (K Units) Figure 20. Europe C1 Esterase Inhibitors Sales YoY (2021-2032) & (K Units) Figure 21. China C1 Esterase Inhibitors Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) C1 Esterase Inhibitors Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa C1 Esterase Inhibitors Sales YoY (2021-2032) & (K Units) Figure 24. Global C1 Esterase Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global C1 Esterase Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global C1 Esterase Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global C1 Esterase Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global C1 Esterase Inhibitors Revenue Market Share by Type (2021-2032) Figure 30. Global C1 Esterase Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global C1 Esterase Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global C1 Esterase Inhibitors Sales Market Share by Type (2021-2032) Figure 33. Global C1 Esterase Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global C1 Esterase Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global C1 Esterase Inhibitors Revenue Market Share by Application (2021-2032) Figure 36. Global C1 Esterase Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global C1 Esterase Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global C1 Esterase Inhibitors Sales Market Share by Application (2021-2032) Figure 39. North America C1 Esterase Inhibitors Revenue Share by Type (2021-2032) Figure 40. North America C1 Esterase Inhibitors Sales Share by Type (2021-2032) Figure 41. North America C1 Esterase Inhibitors Revenue Share by Application (2021-2032) Figure 42. North America C1 Esterase Inhibitors Sales Share by Application (2021-2032) Figure 43. North America C1 Esterase Inhibitors Revenue Share by Country (2021-2032) Figure 44. North America C1 Esterase Inhibitors Sales Share by Country (2021-2032) Figure 45. Europe C1 Esterase Inhibitors Revenue Share by Type (2021-2032) Figure 46. Europe C1 Esterase Inhibitors Sales Share by Type (2021-2032) Figure 47. Europe C1 Esterase Inhibitors Revenue Share by Application (2021-2032) Figure 48. Europe C1 Esterase Inhibitors Sales Share by Application (2021-2032) Figure 49. Europe C1 Esterase Inhibitors Revenue Share by Country (2021-2032) Figure 50. Europe C1 Esterase Inhibitors Sales Share by Country (2021-2032) Figure 51. China C1 Esterase Inhibitors Revenue Share by Type (2021-2032) Figure 52. China C1 Esterase Inhibitors Sales Share by Type (2021-2032) Figure 53. China C1 Esterase Inhibitors Revenue Share by Application (2021-2032) Figure 54. China C1 Esterase Inhibitors Sales Share by Application (2021-2032) Figure 55. Asia C1 Esterase Inhibitors Revenue Share by Type (2021-2032) Figure 56. Asia C1 Esterase Inhibitors Sales Share by Type (2021-2032) Figure 57. Asia C1 Esterase Inhibitors Revenue Share by Application (2021-2032) Figure 58. Asia C1 Esterase Inhibitors Sales Share by Application (2021-2032) Figure 59. Asia C1 Esterase Inhibitors Revenue Share by Country (2021-2032) Figure 60. Asia C1 Esterase Inhibitors Sales Share by Country (2021-2032) Figure 61. SAMEA C1 Esterase Inhibitors Revenue Share by Type (2021-2032) Figure 62. SAMEA C1 Esterase Inhibitors Sales Share by Type (2021-2032) Figure 63. SAMEA C1 Esterase Inhibitors Revenue Share by Application (2021-2032) Figure 64. SAMEA C1 Esterase Inhibitors Sales Share by Application (2021-2032) Figure 65. SAMEA C1 Esterase Inhibitors Revenue Share by Country (2021-2032) Figure 66. SAMEA C1 Esterase Inhibitors Sales Share by Country (2021-2032) Figure 67. C1 Esterase Inhibitors Value Chain Figure 68. Manufacturing Cost Structure Figure 69. C1 Esterase Inhibitors Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant C1-INH
  • Plasma-derived C1-INH
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Takeda
  • Pharming Healthcare
  • CSL Behring

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 C1 Esterase Inhibitors Market by Type
  3. 1.2.1 Global C1 Esterase Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant C1-INH
  5. 1.2.3 Plasma-derived C1-INH
  6. 1.3 C1 Esterase Inhibitors Market by Application
  7. 1.3.1 Global C1 Esterase Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital and Clinic
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 C1 Esterase Inhibitors Market Dynamics
  1. 2.1 C1 Esterase Inhibitors Industry Trends
  2. 2.2 C1 Esterase Inhibitors Industry Drivers
  3. 2.3 C1 Esterase Inhibitors Industry Opportunities and Challenges
  4. 2.4 C1 Esterase Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global C1 Esterase Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global C1 Esterase Inhibitors Revenue by Region
  3. 3.2.1 Global C1 Esterase Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global C1 Esterase Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global C1 Esterase Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global C1 Esterase Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global C1 Esterase Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global C1 Esterase Inhibitors Sales by Region
  9. 3.4.1 Global C1 Esterase Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global C1 Esterase Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global C1 Esterase Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global C1 Esterase Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global C1 Esterase Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global C1 Esterase Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global C1 Esterase Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global C1 Esterase Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global C1 Esterase Inhibitors Sales by Manufacturers
  6. 4.2.1 Global C1 Esterase Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global C1 Esterase Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global C1 Esterase Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global C1 Esterase Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global C1 Esterase Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global C1 Esterase Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global C1 Esterase Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global C1 Esterase Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global C1 Esterase Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 C1 Esterase Inhibitors Tier 1, Tier 2, and Tier 3
5 C1 Esterase Inhibitors Market by Type
  1. 5.1 Global C1 Esterase Inhibitors Revenue by Type
  2. 5.1.1 Global C1 Esterase Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global C1 Esterase Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global C1 Esterase Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global C1 Esterase Inhibitors Sales by Type
  6. 5.2.1 Global C1 Esterase Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global C1 Esterase Inhibitors Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global C1 Esterase Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global C1 Esterase Inhibitors Price by Type
6 C1 Esterase Inhibitors Market by Application
  1. 6.1 Global C1 Esterase Inhibitors Revenue by Application
  2. 6.1.1 Global C1 Esterase Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global C1 Esterase Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global C1 Esterase Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global C1 Esterase Inhibitors Sales by Application
  6. 6.2.1 Global C1 Esterase Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global C1 Esterase Inhibitors Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global C1 Esterase Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global C1 Esterase Inhibitors Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda C1 Esterase Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda C1 Esterase Inhibitors Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Pharming Healthcare
  8. 7.2.1 Pharming Healthcare Company Information
  9. 7.2.2 Pharming Healthcare Business Overview
  10. 7.2.3 Pharming Healthcare C1 Esterase Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pharming Healthcare C1 Esterase Inhibitors Product Portfolio
  12. 7.2.5 Pharming Healthcare Recent Developments
  13. 7.3 CSL Behring
  14. 7.3.1 CSL Behring Company Information
  15. 7.3.2 CSL Behring Business Overview
  16. 7.3.3 CSL Behring C1 Esterase Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CSL Behring C1 Esterase Inhibitors Product Portfolio
  18. 7.3.5 CSL Behring Recent Developments
8 North America
  1. 8.1 North America C1 Esterase Inhibitors Market Size by Type
  2. 8.1.1 North America C1 Esterase Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America C1 Esterase Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America C1 Esterase Inhibitors Price by Type (2021-2032)
  5. 8.2 North America C1 Esterase Inhibitors Market Size by Application
  6. 8.2.1 North America C1 Esterase Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America C1 Esterase Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America C1 Esterase Inhibitors Price by Application (2021-2032)
  9. 8.3 North America C1 Esterase Inhibitors Market Size by Country
  10. 8.3.1 North America C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America C1 Esterase Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe C1 Esterase Inhibitors Market Size by Type
  2. 9.1.1 Europe C1 Esterase Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe C1 Esterase Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe C1 Esterase Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe C1 Esterase Inhibitors Market Size by Application
  6. 9.2.1 Europe C1 Esterase Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe C1 Esterase Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe C1 Esterase Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe C1 Esterase Inhibitors Market Size by Country
  10. 9.3.1 Europe C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe C1 Esterase Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China C1 Esterase Inhibitors Market Size by Type
  2. 10.1.1 China C1 Esterase Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China C1 Esterase Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China C1 Esterase Inhibitors Price by Type (2021-2032)
  5. 10.2 China C1 Esterase Inhibitors Market Size by Application
  6. 10.2.1 China C1 Esterase Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China C1 Esterase Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China C1 Esterase Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia C1 Esterase Inhibitors Market Size by Type
  2. 11.1.1 Asia C1 Esterase Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia C1 Esterase Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia C1 Esterase Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia C1 Esterase Inhibitors Market Size by Application
  6. 11.2.1 Asia C1 Esterase Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia C1 Esterase Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia C1 Esterase Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia C1 Esterase Inhibitors Market Size by Country
  10. 11.3.1 Asia C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia C1 Esterase Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA C1 Esterase Inhibitors Market Size by Type
  2. 12.1.1 SAMEA C1 Esterase Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA C1 Esterase Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA C1 Esterase Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA C1 Esterase Inhibitors Market Size by Application
  6. 12.2.1 SAMEA C1 Esterase Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA C1 Esterase Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA C1 Esterase Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA C1 Esterase Inhibitors Market Size by Country
  10. 12.3.1 SAMEA C1 Esterase Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA C1 Esterase Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA C1 Esterase Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 C1 Esterase Inhibitors Value Chain Analysis
  2. 13.1.1 C1 Esterase Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 C1 Esterase Inhibitors Production Mode & Process
  6. 13.2 C1 Esterase Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 C1 Esterase Inhibitors Distributors
  9. 13.2.3 C1 Esterase Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst